Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR2 | P41597 | 9/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | MMP1 | P03956 | 3/20 | 0.37 |
| ▸ | MMP3 | P08254 | 2/20 | 0.37 |
| ▸ | CTSD | P07339 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | MMP7 | P09237 | 1/20 | 0.36 |
| ▸ | MMP8 | P22894 | 1/20 | 0.36 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.35 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.35 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.35 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.35 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.35 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.35 |
| ▸ | ACE | P12821 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12875886 | 1.00 | CCR2 (0.41) | CCR2HTTL3MBTL1KDM4EALDH1A1 | |
| SCHEMBL10160076 | 0.94 | L3MBTL1 (0.43) | CCR2HTTL3MBTL1KDM4EALDH1A1 | |
| SCHEMBL6734281 | 0.94 | L3MBTL1 (0.43) | CCR2HTTL3MBTL1KDM4EALDH1A1 | |
| SCHEMBL12210573 | 0.94 | L3MBTL1 (0.43) | CCR2HTTL3MBTL1KDM4EALDH1A1 | |
| SCHEMBL12210527 | 0.85 | — | — | |
| SCHEMBL10160080 | 0.85 | — | — | |
| SCHEMBL6727176 | 0.85 | — | — | |
| SCHEMBL7624107 | 0.81 | HTT (0.42) | CCR2HTTL3MBTL1ALDH1A1MMP1 | |
| SCHEMBL28358586 | 0.81 | HTT (0.39) | CCR2HTTL3MBTL1KDM4EALDH1A1 | |
| SCHEMBL28354951 | 0.80 | HTT (0.38) | CCR2HTTL3MBTL1KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6197737-B1 | MIXTURE CONTAINING PEROXYGEN BLEACHES | THE PROCTER & GAMBLE COMPANY | 2001-03-06 | — | — | US | claimed |
| US-4003907-A | Δ1 -1-Azacycloalkene-2-carboxylic acids and their production | BAYER AKTIENGESELLSCHAFT (DT) | 1977-01-18 | — | — | US | claimed |
| CN-109689392-A | The composition and its method of absorbable ink-jet | R.R.当纳利父子公司 | 2019-04-26 | — | — | CN | disclosed |
| EP-3161076-A1 | INK COMPOSITION INCLUDING POLYURETHANE | R. R. Donnelley & Sons Company (US) | 2017-05-03 | — | — | EP | disclosed |
| CN-106459361-A | Polymer dispersions containine acylmorpholines | 巴斯夫欧洲公司 | 2017-02-22 | — | — | CN | disclosed |
| WO-2015200670-A1 | INK COMPOSITION INCLUDING POLYURETHANE | R.R. DONNELLEY & SONS COMPANY (US) | 2015-12-30 | — | — | WO | disclosed |
| EP-2386418-B1 | Method of high-speed variable printing | MOORE WALLACE NORTH AMERICA (US) | 2013-07-03 | — | — | EP | disclosed |
| US-8367666-B2 | 3-carbamoyl-2-pyridone derivatives | SHIONOGI & CO., LTD. (JP) | 2013-02-05 | — | — | US | disclosed |
| US-8178681-B2 | methyl 3-methyl-2-{[2-oxo-1-(2-oxo-ethyl)-1,2,5,6,7,8,9,10-octahydro-cycloocta[b]pyridine-3-carbonyl]-amino}-butyrate; cannabinoid receptor agonist; antiinflammatory agent, immunostimulant, analgesic; atopic dermatitis; excellent in photostability, and have excellent transdermal and oral absorbency | SHIONOGI & CO., LTD. (JP) | 2012-05-15 | — | — | US | disclosed |
| EP-2190672-A1 | NANOPARTICLE-BASED COMPOSITIONS COMPATIBLE WITH JET PRINTING AND METHODS THEREFOR | Moore Wallace North America, Inc. (US) | 2010-06-02 | — | — | EP | disclosed |
| US-7550453-B2 | Anticancer agents; colon cancer or hepatocellular carcinoma; analogs of bengamide where the caprolactam ring is changed and/or substituted e.g. N-(2-Methyl-3-oxo-2,3,4,5-tetrahydro-1H-2-benzazepin-4-yl)-(E)-(2R,3R,4S,5R)-3,4,5-trihydroxy-2-methoxy-8,8-dimethylnon-6-enamide | AVENTIS PHARMA SA (FR) | 2009-06-23 | — | — | US | disclosed |
| US-7550453-B2 | Anticancer agents; colon cancer or hepatocellular carcinoma; analogs of bengamide where the caprolactam ring is changed and/or substituted e.g. N-(2-Methyl-3-oxo-2,3,4,5-tetrahydro-1H-2-benzazepin-4-yl)-(E)-(2R,3R,4S,5R)-3,4,5-trihydroxy-2-methoxy-8,8-dimethylnon-6-enamide | AVENTIS PHARMA SA (FR) | 2009-06-23 | — | — | US | disclosed |
| WO-2009025809-A1 | NANOPARTICLE-BASED COMPOSITIONS COMPATIBLE WITH JET PRINTING AND METHODS THEREFOR | RR DONNELLEY (US) | 2009-02-26 | — | — | WO | disclosed |
| EP-2010240-A2 | MEDICAL DEVICES HAVING ELECTRICALLY ALIGNED ELONGATED PARTICLES | Boston Scientific Limited (BB) | 2009-01-07 | — | — | EP | disclosed |
| WO-2007103356-A2 | MEDICAL DEVICES HAVING ELECTRICALLY ALIGNED ELONGATED PARTICLES | BOSTON SCIENTIFIC LIMITED (BB) | 2007-09-13 | — | — | WO | disclosed |
| EP-0400411-A2 | Aromatic polyethersulphones | BAYER AG (DE) | 1990-12-05 | — | — | EP | disclosed |
| EP-0362603-A1 | Aromatic Polyethersulfones | BAYER AG (DE) | 1990-04-11 | — | — | EP | disclosed |